framycetin has been researched along with Neoplasms in 152 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 142 (93.42) | 18.7374 |
1990's | 3 (1.97) | 18.2507 |
2000's | 3 (1.97) | 29.6817 |
2010's | 3 (1.97) | 24.3611 |
2020's | 1 (0.66) | 2.80 |
Authors | Studies |
---|---|
Di Giorgio, A; Duca, M; Tran, TP; Vo, DD | 1 |
ANDREETTI, C; FERDET, J; PENAU, H; SAIAS, E | 1 |
Hirukawa, S; Hu, GF; Olson, KA; Tsuji, T | 1 |
Ekert, H; Jurk, IH; Tiedemann, K; Waters, KD | 1 |
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
Bittinger, K; Bushman, FD; Facciabene, A; Ganetsky, A; Gill, S; Guedan, S; June, CH; Morgan, MA; Pierini, S; Rafail, S; Tanes, C; Tanyi, JL; Uribe-Herranz, M | 1 |
AMANIERA, G; BERTIGLIA, B; EMILIANI, G | 1 |
Chen, X; Kim, JY; Lee, S; Yoon, J | 1 |
FALK, MS | 1 |
RENAUD, S | 2 |
FRICKE, W; TOUSSAINT, R; ZERLETT, G | 1 |
CABRAI, F | 1 |
CALABRESI, P | 1 |
CALCUTT, G | 1 |
CALDERON, HI; LOSADA, A; VILLARQUIDE, G | 1 |
CALLAO FABREGAT, V | 1 |
CALLAWAY, E | 1 |
CALUSIO, R | 4 |
CAMERON, JM; LITTON, A; LYON, DS | 1 |
CAMPOS, S | 1 |
CANDARDJIS, G | 1 |
CANGELLO, VW | 1 |
CANTAROW, A; RUPP, JJ | 1 |
CAPPUCCINO, JG; REILLY, HC; WINSTON, S | 1 |
CAPROTTI, M; STRANEO, G | 1 |
CARRERA, F; MARTINENGHI, C | 1 |
CASPERSSON, T | 1 |
CATER, DB; SCHOENIGER, EL; WATKINSON, DA | 1 |
CHAKLIN, AV | 2 |
CHAMPY-HATEM, S | 1 |
CHANG, CF | 1 |
CHAVY, A; PIET, R | 1 |
CAMERON, WR; CHEN, WY; CRITTENDEN, LB; MANTEL, N | 1 |
CHIEN, HC | 1 |
CHIURCO, GA | 1 |
ABBOZZO, G; CIAMPELLI, L | 1 |
CIESZYNSKI, T | 1 |
CLARK, AC | 1 |
CLEMMESEN, J | 1 |
COHEN, D; LEE, CW | 1 |
COLE, WH | 1 |
COLELLA, AC; REITH, WS; WILLIAMS, ES | 1 |
COLLINA, G | 1 |
CONDIT, PT; OWENS, AH; SHNIDER, BI | 1 |
COPELAND, MM | 1 |
COOK, ES; COSBY, MI; NUTINI, LG; SPERTI, GS | 1 |
CEIA, M; CHAVES, FJ; CRESPO, EV; da COSTA, S; da SILVA, J | 1 |
COSTACHEL, O; ILIE, B; NASTAC, E | 1 |
COURT BROWN, WM | 1 |
COYLE, JE | 1 |
CRASILNECK, HB; HALL, JA | 1 |
CREECH, O; KREMENTZ, ET | 1 |
CREWS, QE | 1 |
CRILE, G | 1 |
CRISTIANI, G | 1 |
CROSTA, C | 1 |
CUERVO GARCIA, C | 1 |
CURRERI, AR | 1 |
CURTIS, JM | 1 |
CUTLER, SJ; EDERER, F | 1 |
DAHLE, T | 1 |
DAHLGREN, S | 1 |
DAJANI, RM; DANIELSKI, J; GAMBLE, W; ORTEN, JM | 1 |
DANCOT, H | 1 |
DARCY, DA | 1 |
BURCHENAL, JH; DARGEON, HW; MURPHY, ML; TAN, C | 1 |
DAVIES, JN; KNOWELDEN, J; WILSON, BA | 1 |
DAVIES, JN | 1 |
DAY, E; VENET, L | 1 |
DAY, ED | 1 |
CARTER, D; DE CARTER, C | 1 |
DE HARVEN, E | 1 |
DE LA PAVA, S; NIGOGOSYAN, G; PICKREN, JW | 1 |
DE LAURENZI, A | 1 |
DE LEON, J; MACDONALD, A | 2 |
DE PEYSTER, FA; JOBGEN, EA; PETRAVICIUS, MA | 1 |
DE TOROK, D; RODERICK, TH | 1 |
CAULET, T; DELARUE, J; MIGNOT, J | 1 |
DELMAR, A; SACERDOTE DE LUSTIG, E; SASKO, C; SCHCOLNICOV, B; YANEZ, M | 1 |
BIRABEN, J; DELMON, G | 1 |
DENOIX, P | 1 |
DENOIX, PF | 1 |
DERINGER, MK | 1 |
DI SILVERIO, B; DI SILVERIO, S | 1 |
DOEHNER, L | 1 |
BRADA, Z; DOLEZALOVA, V | 1 |
DONTENWILL, W | 2 |
DOUGLAS, JR | 1 |
DU MESNIL DE ROCHEMONT, R; STENDER, HS | 1 |
DINH BAO, L; DUFOUR, D; LINSAY, P | 1 |
DUFOUR, D; LINH, DB | 2 |
BITENSKY, L; CHAYEN, J; CUNNINGHAM, GJ; DUMONDE, DC; WALTER, CM | 1 |
AYVAZIAN, JH; DUMONT, AE; McCLUSKEY, RT | 1 |
DUNN, MS; MURPHY, EA; SAKAMOTO, K; SUTARIA, PB | 1 |
CZARNOMSKA, A; DUX, K; RYZEWSKA, A | 1 |
DVOIRIN, VV | 1 |
BEAL, JM; CAHOW, CE; CONN, J; CORNELL, GN; ECKER, RR | 1 |
EDER, M; WRBA, H | 1 |
EFUNI, IuN; KARIAKIN, AV | 1 |
EGER, H | 1 |
EHRHART, H; FISCHER, T | 1 |
EISEN, HN | 1 |
EKER, R | 1 |
ELANSKII, NN | 1 |
ELKIND, MM | 1 |
ELLIS, DB; SCHOLEFIELD, PG | 1 |
ENDICOTT, KM | 1 |
EPSTEIN, SS; TIMMIS, GM | 1 |
ERLANGER, G | 1 |
ERLICH, DH | 1 |
ESTRADA, S | 1 |
EVANG, K | 1 |
EVANS, AD; HORTON, DL; WHITELEY, HJ | 1 |
EAKINS, D; FULTON, T; HADDEN, DR | 1 |
FAIRMAN, HD; HADLEY, SK; JOHN, HT | 1 |
COHN, I; CORLEY, RG; FLOYD, CE | 1 |
FRIEDMAN, J; STENSTROM, KW | 1 |
KLEIN, G | 1 |
GIGLI, G | 1 |
HAYASHI, T; MORI, S; NONOUCHI, Y; OJIMA, A; SAKATOKU, J | 1 |
ARMISTEAD, GC; BERNSTEIN, JL; BURCHENAL, JH; CRAVER, LF; KARNOFSKY, DA; RHOADS, CP; SOUTHAM, CM | 1 |
ZABEL, W | 1 |
WHITE, PR | 1 |
REICHMAN, HR | 1 |
DEGOS, R; DUPERRAT, B | 1 |
BUNTING, H; CHEATUM, EL | 1 |
KLEIN, M | 1 |
HALPERT, B | 1 |
LI, IY; ORTEGA, P; SHIMKIN, M | 1 |
REITANO, U | 1 |
ELIEL, LP; PEARSON, OH | 1 |
Hammerschmidt, S; Langmann, P; Scheppach, W; Wahn, H | 1 |
de Bruijn, P; de Jonge, MJ; Kehrer, DF; Nierop, CA; Ruijgrok, EJ; Sparreboom, A; van de Schraaf, J; Verweij, J | 1 |
Babinet, C; Lafon, I; Langa, F; Morello, D; Vandormael-Pournin, S; Vidaud, M | 1 |
Favrot, MC; Philip, T | 1 |
Rosenberg, SA | 1 |
Fireman, BH; Friedman, GD; Selby, JV | 1 |
Enoki, Y; Niwa, O; Yokoro, K | 1 |
Culliton, BJ | 1 |
Marwick, C | 1 |
Bourgeois, LD; Hazen, JG; Levitan, AA | 1 |
Bruckner, HW; Creasey, WA | 1 |
Smolianskaia, AZ | 1 |
Grinenko, GI; Smolianskaia, AZ | 1 |
3 review(s) available for framycetin and Neoplasms
Article | Year |
---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Recent progress in stimuli-induced polydiacetylenes for sensing temperature, chemical and biological targets.
Topics: Amines; Animals; Anions; Bacteria; Enzymes; Gases; Humans; Hydrocarbons; Ions; Metals; Neomycin; Neoplasms; Polyacetylene Polymer; Polymers; Polyynes; Surface-Active Agents; Temperature; Viruses; Water | 2016 |
[Clonal evolution in tumor cell population].
Topics: Animals; Biological Evolution; DNA Repair; DNA Replication; DNA, Neoplasm; Drug Resistance; Genetic Markers; Genetic Variation; Humans; Methylation; Mice; Neomycin; Neoplasms; Nondisjunction, Genetic; Sarcoma, Experimental; Selection, Genetic; Tumor Cells, Cultured | 1989 |
3 trial(s) available for framycetin and Neoplasms
Article | Year |
---|---|
Prophylactic co-trimoxazole and lactobacilli preparation in neutropenic patients.
Topics: Agranulocytosis; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Biological Products; Child; Child, Preschool; Colistin; Drug Combinations; Framycetin; Humans; Lactobacillus; Neoplasms; Neutropenia; Nystatin; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1980 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Modulation of irinotecan-induced diarrhea by cotreatment with neomycin in cancer patients.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Cross-Over Studies; Diarrhea; Humans; Irinotecan; Middle Aged; Neomycin; Neoplasms | 2001 |
147 other study(ies) available for framycetin and Neoplasms
Article | Year |
---|---|
Ribosome-targeting antibiotics as inhibitors of oncogenic microRNAs biogenesis: Old scaffolds for new perspectives in RNA targeting.
Topics: Aminoglycosides; Anti-Bacterial Agents; Base Sequence; DEAD-box RNA Helicases; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Models, Molecular; Molecular Sequence Data; Neoplasms; Ribonuclease III; Ribosomes; Tetracyclines | 2015 |
[Determination of framycetin in industrial culture media].
Topics: Anti-Bacterial Agents; Culture Media; Dermatologic Agents; Framycetin; Neoplasms; Sarcoma | 1954 |
Neamine inhibits xenografic human tumor growth and angiogenesis in athymic mice.
Topics: Active Transport, Cell Nucleus; Aminoglycosides; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Nucleus; Cell Proliferation; Endothelial Cells; Framycetin; Humans; Mice; Mice, Nude; Neoplasms; Neovascularization, Pathologic; Ribonuclease, Pancreatic; Umbilical Veins; Xenograft Model Antitumor Assays | 2005 |
Gut microbiota modulates adoptive cell therapy via CD8α dendritic cells and IL-12.
Topics: Adult; Aged; Animals; Bacteria; CD8 Antigens; Cell Line, Tumor; Cohort Studies; Dendritic Cells; Disease Models, Animal; Fecal Microbiota Transplantation; Female; Gastrointestinal Microbiome; Hematopoietic Stem Cell Transplantation; Host Microbial Interactions; Humans; Immunotherapy, Adoptive; Interleukin-12; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Neomycin; Neoplasms; T-Lymphocytes; Treatment Outcome; Vancomycin | 2018 |
[Phillips-Van Slyke test in the study of neoplastic diseases submitted to radiotherapy].
Topics: Blood; Neomycin; Neoplasms | 1950 |
An appraisal of compound F (hydrocortisone acetate)-neomycin ointment in clinical dermatology.
Topics: Adrenal Cortex; Adrenal Cortex Hormones; Dermatology; Hydrocortisone; Neomycin; Neoplasms; Ointments; Skin Diseases | 1955 |
The potentiating effect of tumors on neomycin toxicity.
Topics: Neomycin; Neoplasms; Neoplasms, Experimental | 1960 |
[Aerosol therapy of concomitant infections in bronchial carcinoma with neomycin and bacitracin].
Topics: Aerosols; Bacitracin; Bronchi; Bronchial Neoplasms; Carcinoma, Bronchogenic; Humans; Neomycin; Neoplasms | 1959 |
[On the anti-proliferative and anti-tumor activity of mytomycin C].
Topics: Humans; Mitomycin; Neomycin; Neoplasms | 1961 |
Regional protection in cancer chemotherapy. 1. Infusions of thymidine into external carotid artery of patients receiving systemic 5-iodo-2'-deoxyuruidine.
Topics: Antimetabolites; Carotid Artery, External; Neomycin; Neoplasms; Nucleosides; Nucleotides; Thymidine | 1962 |
Sulphydryl groups and tumour induction by chemical agents.
Topics: Neomycin; Neoplasms; Sulfhydryl Compounds | 1961 |
[Gamma globulin and the diagnosis of cancer].
Topics: gamma-Globulins; Neomycin; Neoplasms | 1961 |
[The microbial equivalents of the cancer cell].
Topics: Humans; Neomycin; Neoplasms | 1962 |
The importance of nuclear medicine to cancer control.
Topics: Neomycin; Neoplasms; Nuclear Medicine | 1961 |
[Early hematological diagnosis of cancer by the colorimetric method of Dr. Jolles Fonti].
Topics: Colorimetry; Early Diagnosis; Erythrocytes; Neomycin; Neoplasms | 1962 |
[The blood in cancer patients].
Topics: Blood Transfusion; Neomycin; Neoplasms; Transfusion Reaction | 1962 |
[The predisposition to and symptomatology of cancer].
Topics: Disease Susceptibility; Humans; Neomycin; Neoplasms | 1962 |
[Transmissibility of malignant tumors].
Topics: Neomycin; Neoplasms | 1962 |
Primary carcinoma multiplex.
Topics: Carcinoma; Female; Humans; Medical Records; Neomycin; Neoplasms | 1961 |
[The combination of chlormethazone and dipyrone in cancer pain].
Topics: Analgesics; Analgesics, Non-Narcotic; Antipyretics; Dipyrone; Neomycin; Neoplasms; Pain Management; Tranquilizing Agents | 1961 |
[General indications for radiotherapy of malignant tumors].
Topics: Neomycin; Neoplasms | 1962 |
Hypnosis for the patient with cancer.
Topics: Humans; Hypnosis; Neomycin; Neoplasms; Pain Management | 1962 |
Effects of 5-fluorouracil on the adrenals of normal and tumor-bearing rats.
Topics: Adrenal Glands; Animals; Cortisone; Fluorouracil; Neomycin; Neoplasms; Rats; Uracil | 1962 |
Elevation of lysozyme in extracts of kidneys and spleens from tumor-bearing animals.
Topics: Animals; Kidney; Muramidase; Neomycin; Neoplasms; Spleen | 1962 |
[Considerations on mitotic changes induced in Ehrlich ascites carcinoma by aging of the tumor and by the action of ionizing radiations].
Topics: Ascites; Carcinoma; Neomycin; Neoplasms; Radiation, Ionizing | 1961 |
[Behavior of some immunohematological tests in patients with neoplasms treated with telecobaltotherapy. I. Behavior of the anti-erythrocyte antibodies].
Topics: Antibodies; Erythrocytes; Mononuclear Phagocyte System; Neomycin; Neoplasms | 1961 |
Quantitative cytochemistry for the study of normal and abnormal growth.
Topics: Growth; Histocytochemistry; Neomycin; Neoplasms; Nucleic Acids; Physiological Phenomena | 1961 |
Effects on oxygen tension of tumours of breathing oxygen at high pressures.
Topics: Humans; Monitoring, Physiologic; Neomycin; Neoplasms; Oxygen; Pressure | 1962 |
[Problems in organization of anticancer control and regional features in the spread of malignant tumors].
Topics: Humans; Neomycin; Neoplasms | 1960 |
[Some aspects of 5 expeditions for the study of regional characteristics of the distribution of malignant tumors].
Topics: Biometry; Expeditions; Humans; Neomycin; Neoplasms | 1961 |
[Chromium cancers and the chromiumimidazole complex].
Topics: Carcinogens; Chromium; Humans; Imidazoles; Neomycin; Neoplasms | 1962 |
[Soviet anticancer work: a report of studies in the Soviet Union, their organizational and research work in combating cancer].
Topics: Biomedical Research; Humans; Neomycin; Neoplasms; Research; USSR | 1960 |
[Apropos of simultaneous or successive multiple cancers].
Topics: Humans; Neomycin; Neoplasms | 1962 |
Site distribution of cancer deaths in husband-wife and sibling pairs.
Topics: Humans; Neomycin; Neoplasms; Siblings; Spouses | 1961 |
[Cancer prevention research must strive for newer achievements on the basis of the victories gained].
Topics: Achievement; Biomedical Research; Humans; Neomycin; Neoplasms; Research | 1960 |
[Early diagnosis and individual prevention of preneoplastic states and beginning tumors].
Topics: Biomedical Research; Early Diagnosis; Humans; Neomycin; Neoplasms; Precancerous Conditions | 1962 |
[Behavior of immune hemoagglutinins in patients with malignant neoplasms subjected to radiation treatment].
Topics: Hemagglutination; Neomycin; Neoplasms | 1961 |
The optical transmittance of solutions of human fat in various surgical conditions with special regard to cancer disease.
Topics: Adipose Tissue; Humans; Neomycin; Neoplasms | 1962 |
Chemotherapy in malignant disorders of childhood.
Topics: Antineoplastic Agents; Child; Infant; Neomycin; Neoplasms; Syndrome | 1962 |
[Results of 20 years of cancer registration].
Topics: Humans; Neomycin; Neoplasms | 1962 |
Malignant disease in childhood.
Topics: Child; Infant; Neomycin; Neoplasms; Syndrome | 1961 |
The relationship between duration of symptoms and results of treatment in cancer patients.
Topics: Neomycin; Neoplasms | 1962 |
The radioactive triolein test in malignant disease.
Topics: Intestine, Small; Intestines; Neomycin; Neoplasms; Radiometry; Syndrome; Triolein | 1961 |
[Review of cancerology 1961].
Topics: Humans; Neomycin; Neoplasms | 1962 |
Studies on the folic acid vitamins. VII. The effects of large doses of amethopterin in patients with cancer.
Topics: Adenocarcinoma; Carcinoma; Carcinoma, Squamous Cell; Folic Acid; Folic Acid Antagonists; Methotrexate; Neomycin; Neoplasms; Vitamins | 1962 |
The clinical care of the cancer patient both curative and palliative.
Topics: Humans; Neomycin; Neoplasms | 1961 |
Induction of resistance to an isologous tumour by ultra-violet attenuated tumour cells.
Topics: Biochemical Phenomena; Humans; Neomycin; Neoplasms; Ultraviolet Rays; Viola | 1962 |
[Immuno-electrophoresis of the blood proteins in cases of malignant neoplasms (preliminary observations)].
Topics: Blood Proteins; Immunoelectrophoresis; Neomycin; Neoplasms | 1961 |
[The action of some viruses, associated with cytostatic drugs, on T8 Guerin tumors].
Topics: Antineoplastic Agents; Cytostatic Agents; Humans; Neomycin; Neoplasms; Viruses | 1961 |
Role of genetic change in neoplasia.
Topics: Humans; Neomycin; Neoplasms | 1962 |
Present status of radiation therapy of malignant disease.
Topics: Neomycin; Neoplasms | 1962 |
The use of hypnosis with unconscious patients.
Topics: Humans; Hypnosis; Neomycin; Neoplasms; Unconsciousness | 1962 |
Cancer chemotherapy by perfusion.
Topics: Antineoplastic Agents; Humans; Neomycin; Neoplasms; Perfusion | 1961 |
Observations on the combined use of 5-fluorouracil and 2 Mev radiation in advanced solid tumors in man.
Topics: Antineoplastic Agents; Fluorouracil; Neomycin; Neoplasms; Radiation; Research; Uracil | 1961 |
Selective destruction of cancers after exposure to heat.
Topics: Diathermy; Heart; Hot Temperature; Humans; Hyperthermia, Induced; Neomycin; Neoplasms; Radiotherapy | 1962 |
[Cancer and old age].
Topics: Aged; Aged, 80 and over; Humans; Neomycin; Neoplasms | 1961 |
[Diagnostic efficacy of abdominal aortography in some extraperitoneal tumors of difficult interpretation].
Topics: Abdomen; Abdominal Neoplasms; Angiography; Aortography; Humans; Neomycin; Neoplasms | 1962 |
[Desoxyribonucleic acid and cancer. (Introduction)].
Topics: DNA; Neomycin; Neoplasms | 1961 |
The role of the medical school in cancer education.
Topics: Education, Nursing; Hospitals; Humans; Neomycin; Neoplasms; Schools; Schools, Medical | 1960 |
Cancer detection in a country practice.
Topics: Humans; Neomycin; Neoplasms | 1962 |
End results and mortality trends in cancer. I. End results in cancer.
Topics: Biometry; Humans; Neomycin; Neoplasms | 1961 |
[Mass examinations and cancer].
Topics: Biomedical Research; Humans; Neomycin; Neoplasms; Physical Examination | 1962 |
Thorotrast tumours. A review of the literature and report of two cases.
Topics: Neomycin; Neoplasms; Thorium; Thorium Dioxide | 1961 |
Astudy of the citric acid cycle in certain tumour tissue.
Topics: Citric Acid Cycle; Humans; Metabolism; Neomycin; Neoplasms | 1961 |
[Study of the radiocurability of primary lesions at onset in the group of so-called radiosensitive cancers. Epithelioma of the endolarynx. Epithelioma of the palatine tonsil].
Topics: Carcinoma; Humans; Laryngeal Neoplasms; Larynx; Neomycin; Neoplasms; Palatine Tonsil; Tonsillar Neoplasms | 1962 |
[Studies on the virology and immunology of cancer].
Topics: Neomycin; Neoplasms | 1962 |
Chemotherapy in juvenile cancers.
Topics: Antineoplastic Agents; Child; Humans; Infant; Neomycin; Neoplasms | 1961 |
Cancer incidence of the African population of Kyadondo (Uganda).
Topics: Black People; Humans; Incidence; Neomycin; Neoplasms; Uganda | 1962 |
The pattern of African cancer in Uganda.
Topics: Humans; Neomycin; Neoplasms; Uganda | 1961 |
Periodic cancer detection examinations as a cancer control measure.
Topics: Biomedical Research; Humans; Neomycin; Neoplasms; Physical Examination | 1960 |
Biochemistry of cancer.
Topics: Humans; Neomycin; Neoplasms | 1962 |
[Some problems of public health in the USA and the USSR. Preventive medicine in cancer and its present scope].
Topics: Biomedical Research; Biometry; Humans; Neomycin; Neoplasms; Preventive Medicine; Public Health; USSR | 1960 |
[Electron microscope study of Friend's leukemia and other mouse cancers also associated with the presence of virus particles].
Topics: Animals; Electrons; Friends; Leukemia; Lymphoma; Mice; Neomycin; Neoplasms; Virion; Viruses | 1961 |
Fatal glomerulonephritis after receiving horse anti-human-cancer serum. Report of three cases.
Topics: Glomerulonephritis; Humans; Immune Sera; Neomycin; Neoplasms | 1962 |
[Use of levorotatory 3-methoxy-10-(2-methyl-3-diethylaminopropyl)-phenothiazine in the pain of cancer patients].
Topics: Analgesics; Analgesics, Non-Narcotic; Antipyretics; Neomycin; Neoplasms; Pain; Phenothiazines; Tranquilizing Agents | 1962 |
[Selective extracorporeal circulation and massive antibiotherapy in the treatment of cancer].
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Extracorporeal Circulation; Neomycin; Neoplasms; Perfusion | 1961 |
[Selective extracorporeal circulation and massive antibiotic therapy in the treatment of cancer].
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Extracorporeal Circulation; Neomycin; Neoplasms; Perfusion | 1961 |
Humoral accelerating effect of regenerating liver on distant tumor take and growth in rats.
Topics: Animals; Body Fluids; Liver; Liver Regeneration; Neomycin; Neoplasms; Rats; Regeneration | 1961 |
Associations between growth rate, mitotic frequency, and chromosome number in a plant tissue culture.
Topics: Cell Division; Chromosomes; Neomycin; Neoplasms; Research Design; Tissue Culture Techniques | 1962 |
[Early changes induced in the cheek pouch of the golden hamster by carcinogenic hydrocwrbons].
Topics: Animals; Benz(a)Anthracenes; Carcinogens; Cheek; Connective Tissue; Cricetinae; Mesocricetus; Neomycin; Neoplasms; Neoplasms, Connective Tissue | 1962 |
[Determination of properdin and inoculation into the chick embryo of the blood serum in multiple sclerosis. Comparative study of results with cancer and neurologic diseases].
Topics: Humans; Multiple Sclerosis; Neomycin; Neoplasms; Nervous System Diseases; Neurology; Properdin; Serum; Vaccination | 1961 |
[Experimental anatomopathological study of the invasive malignancy potential of Guerin's carcinoma T8, according to variations in the toxohormone content of the tumor].
Topics: Catalase; Endotoxins; Liver; Neomycin; Neoplasms | 1962 |
[Importance of host-tumor relations in the development of human cancers].
Topics: Humans; Neomycin; Neoplasms | 1962 |
[The Institut Gustave-Roussy. Structure and function].
Topics: Hospital Administration; Humans; Neomycin; Neoplasms | 1961 |
Development of tumors, especially mammary tumors, in agent-free strain DBA/2eB mice.
Topics: Animals; Breast Neoplasms; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Inbred DBA; Neomycin; Neoplasms | 1962 |
[Failure of attachment of a tumor graft in a rat treated with titanium peroxide hydrate. Rapid development of the tumor after inoculation with cupferron].
Topics: Animals; Iron; Neomycin; Neoplasms; Nitrosamines; Peroxides; Rats; Titanium | 1962 |
[Quantitative studies on preservation of human cells at low temperatures].
Topics: Cell Biology; Cold Temperature; Cytodiagnosis; Humans; Neomycin; Neoplasms; Preservation, Biological; Temperature | 1961 |
[The host-tumor relationship. VI. Release of proteins by tumor cells in vitro].
Topics: Humans; In Vitro Techniques; Neomycin; Neoplasms; Proteins | 1961 |
[Hormonal induction and alteration of tumors and tumor-like tissue proliferations].
Topics: Hormones; Humans; Neomycin; Neoplasms | 1961 |
[Significance of hormones for tumor development].
Topics: Hormones; Humans; Neomycin; Neoplasms | 1961 |
Huxley's criterion of malignancy.
Topics: Humans; Neomycin; Neoplasms | 1962 |
[Medical care and general management of tumor patients during and after radiotherapy].
Topics: Humans; Neomycin; Neoplasms | 1962 |
[Study of the relation between the spleen and the specific antigen of the Walker tumor].
Topics: Antigens; Neomycin; Neoplasms; Spleen | 1962 |
[Immunological sensitization of the rat to the development of the Walker tumor].
Topics: Animals; Immunization; Neomycin; Neoplasms; Rats | 1962 |
[Specificity of the tumor antigen detected in the liver of a rat bearing a Walker tumor].
Topics: Animals; Antigens, Neoplasm; Liver; Neomycin; Neoplasms; Rats; Sensitivity and Specificity | 1962 |
Intracellular response to an iso-immune reaction at the surface of ascites tumour cells.
Topics: Ascites; Cytoplasm; Diploidy; Neomycin; Neoplasms | 1961 |
Incorporation of host nuclear materials into transplanted tumour cells in surgical wounds.
Topics: DNA; Inflammation; Neomycin; Neoplasms; Wounds and Injuries | 1962 |
Amino acid composition of rat and mouse tumors.
Topics: Amino Acids; Animals; Carcinosarcoma; Mice; Neomycin; Neoplasms; Rats; Sarcoma, Experimental | 1962 |
On the mechanism and nature of antigenic changes in the Guerin rat tumour.
Topics: Animals; Neomycin; Neoplasms; Rats | 1962 |
[Some problem of the regional (republic) registration of neoplastic diseases in oncological dispensaries].
Topics: Humans; Neomycin; Neoplasms | 1962 |
Cancer chemotherapy for hepatic metastases by continuous hepatic artery influsion.
Topics: Folic Acid Antagonists; Hepatic Artery; Infusions, Parenteral; Liver Neoplasms; Neomycin; Neoplasms | 1962 |
[Enzyme histochemical research on the biology of ascites tumors and their transformation into solid tumors].
Topics: Animals; Ascites; Biology; Carcinoma, Ehrlich Tumor; Enzymes; Neomycin; Neoplasms; Research | 1961 |
[Spectrum examination of the luminescence of tissues of otorhinolaryngological organs].
Topics: Fluorescent Dyes; Luminescence; Neomycin; Neoplasms; Otolaryngology | 1962 |
[On the problem of the pathogenesis of tumor due to chronic trauma. A case report contribution].
Topics: Artificial Limbs; Humans; Neomycin; Neoplasms; Prostheses and Implants | 1962 |
[Bone marrow function tests in patients with malignant tumors].
Topics: Bone Marrow; Humans; Neomycin; Neoplasms; Vegetables | 1962 |
Immune responses and regression of autochthonous tumors.
Topics: Neomycin; Neoplasms | 1961 |
[Mass examinations and cancer].
Topics: Biomedical Research; Humans; Neomycin; Neoplasms; Physical Examination | 1962 |
[Cancer and precancerous diseases].
Topics: Humans; Neomycin; Neoplasms | 1962 |
Radiation responses of mammalian cells.
Topics: Neomycin; Neoplasms; Physiological Phenomena; Radiation Effects; Radiation Injuries; Tissue Culture Techniques | 1961 |
Studies of fatty acid oxidation. IX. The effects of uncoupling agents on the oxidation of fatty acids by transplantable tumors.
Topics: Fatty Acids; Lipid Metabolism; Neomycin; Neoplasms; Oxidation-Reduction; Uncoupling Agents | 1962 |
The government's role in the overall cancer problem.
Topics: Biomedical Research; Government; Humans; Neomycin; Neoplasms | 1961 |
The effect of selected vitamin B12 antagonists and other compounds on the C1300 mouse tumor.
Topics: Animals; Mice; Neomycin; Neoplasms; Vitamin B 12 | 1962 |
A new pharmacodynamic effect of hydrogen peroxide, and its possible application for tumor studies.
Topics: Electricity; Humans; Hydrogen Peroxide; Neomycin; Neoplasms | 1961 |
[New therapeutic trends in cancer in the United States of North America].
Topics: Humans; Neomycin; Neoplasms; North America; United States | 1961 |
[Immunology and cancer].
Topics: Humans; Neomycin; Neoplasms | 1961 |
[Mass examinations and cancer].
Topics: Biomedical Research; Humans; Neomycin; Neoplasms; Physical Examination | 1962 |
A transplantable tumour of the mouse that is virus-susceptible in tissue culture.
Topics: Animals; Mice; Neomycin; Neoplasm Transplantation; Neoplasms; Research Design | 1962 |
RETICULUM CELL SARCOMA OF THE SMALL BOWEL AND STEATORRHOEA.
Topics: Ascorbic Acid; Blood Transfusion; Body Weight; Bone Marrow Examination; Celiac Disease; Diet; Diet Therapy; Fats; Feces; Folic Acid; Humans; Intestinal Neoplasms; Intestinal Perforation; Intestine, Small; Iron; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Nandrolone; Neomycin; Neoplasms; Pathology; Prednisone; Sarcoma; Steatorrhea; Surgical Procedures, Operative; Vitamin A; Vitamin B 12; Vitamin B Complex; Vitamins; Water-Electrolyte Balance | 1964 |
PHARYNGOLARYNGECTOMY AND COLONIC RECONSTRUCTION. A ONE-STAGE OPERATION FOR CANCER OF THE PHARYNX AND CERVICAL OESOPHAGUS.
Topics: Colon; Esophageal Neoplasms; Geriatrics; Humans; Laryngectomy; Neck Dissection; Neomycin; Neoplasms; Pharyngeal Neoplasms; Pharynx; Surgical Procedures, Operative | 1964 |
LOCAL RECURRENCE OF CARCINOMA OF THE COLON AND RECTUM.
Topics: Colonic Neoplasms; Colostomy; Drug Therapy; Humans; Ileostomy; Kanamycin; Neomycin; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Postoperative Complications; Preoperative Care; Rectal Neoplasms; Rectum; Sulfonamides; Surgical Procedures, Operative; Sutures; Tetracycline | 1965 |
Effect of stress on toxicity and tumor growth inhibition of neomycin.
Topics: Mental Disorders; Neomycin; Neoplasms; Stress, Physiological | 1960 |
Palliative radiation therapy in neoplastic disease.
Topics: Humans; Neomycin; Neoplasms; Palliative Care; Radiation; Research; X-Ray Therapy | 1950 |
Use of the Ehrlich ascites tumor of mice for quantitative studies on the growth and biochemistry of neoplastic cells.
Topics: Animals; Carcinoma, Ehrlich Tumor; Mice; Neomycin; Neoplasms | 1950 |
[Primary neoplasm of the spleen with slight leukemoid reaction].
Topics: Humans; Leukemoid Reaction; Neomycin; Neoplasms; Spleen | 1950 |
Statistical observation of the neoplastic diseases in the endocrine organs.
Topics: Biometry; Endocrine Glands; Humans; Neomycin; Neoplasms | 1950 |
Triethylene melamine in the treatment of neoplastic disease; a compound with nitrogen-mustardlike activity suitable for oral and intravenous use.
Topics: Humans; Infusions, Intravenous; Neomycin; Neoplasms; Nitrogen; Triazines; Triethylenemelamine | 1951 |
[Adjuvant therapy of neoplastic disease].
Topics: Combined Modality Therapy; Humans; Neomycin; Neoplasms | 1951 |
Neoplastic growth in plants.
Topics: Humans; Neomycin; Neoplasms; Plants | 1951 |
Malignancy of the colon in the younger age group.
Topics: Colon; Humans; Neomycin; Neoplasms | 1951 |
[Intraepidermal neoplasms].
Topics: Carcinoma; Humans; Neomycin; Neoplasms; Skin; Skin Neoplasms | 1951 |
Malignant neoplasms in varying hares (Lepus americanus virginianus).
Topics: Animals; Hares; Lagomorpha; Neomycin; Neoplasms; Rabbits | 1951 |
Production of tumors by methylcholanthrene and fetal skin transplanted to different sites in mice.
Topics: Animals; Methylcholanthrene; Mice; Neomycin; Neoplasms; Skin | 1951 |
Neoplasms-expanding, infiltrating, metastasizing.
Topics: Humans; Neomycin; Neoplasms | 1951 |
Metastasis of neoplasms to other neoplasms.
Topics: Humans; Neomycin; Neoplasms; Neoplasms, Second Primary | 1951 |
[Considerations and case reports on neoplasms in the light of opinions expressed by the Collegio Medico-Legale].
Topics: Humans; Jurisprudence; Light; Neomycin; Neoplasms | 1951 |
The clinical and physiologic effects of adrenocorticotropic hormone and cortisone acetate in patients with neoplastic disease.
Topics: Adrenocorticotropic Hormone; Cortisone; Neomycin; Neoplasms | 1951 |
[Acute liver failure after therapeutic hyperthermia].
Topics: Anti-Bacterial Agents; Blood Transfusion; Critical Care; Female; Follow-Up Studies; Gastrointestinal Agents; Humans; Hyperthermia, Induced; Lactulose; Liver Failure, Acute; Middle Aged; Neomycin; Neoplasms; Parenteral Nutrition, Total; Time Factors | 1999 |
Healthy mice with an altered c-myc gene: role of the 3' untranslated region revisited.
Topics: 3' Untranslated Regions; Alleles; Animals; Cell Differentiation; Cell Line; Gene Targeting; Genes, myc; Liver; Liver Regeneration; Mice; Mice, Transgenic; Neomycin; Neoplasms; Proto-Oncogene Proteins c-myc; Response Elements; RNA Stability; RNA, Messenger; Sequence Deletion; Stem Cells | 2001 |
Treatment of patients with advanced cancer using tumor infiltrating lymphocytes transduced with the gene of resistance to neomycin.
Topics: Clinical Protocols; Combined Modality Therapy; Drug Resistance; Genetic Vectors; Humans; Interleukin-2; Lymphocytes, Tumor-Infiltrating; Moloney murine leukemia virus; Neomycin; Neoplasms; Transduction, Genetic | 1992 |
Adoptive immunotherapy for cancer.
Topics: Animals; DNA, Recombinant; Drug Resistance; Genetic Engineering; Genetic Markers; Humans; Immunization, Passive; Immunotherapy; Interleukin-2; Kidney Neoplasms; Killer Cells, Lymphokine-Activated; Lymphocyte Activation; Lymphocytes; Melanoma; Mice; Neomycin; Neoplasms; Retroviridae; Transfection | 1990 |
Screening prescription drugs for possible carcinogenicity: eleven to fifteen years of follow-up.
Topics: Anti-Bacterial Agents; Atropa belladonna; Carcinogens; Drug-Related Side Effects and Adverse Reactions; Erythromycin; Esophageal Neoplasms; Folic Acid; Follow-Up Studies; Gastrointestinal Neoplasms; Lung Neoplasms; Lymphoma, Non-Hodgkin; Multiple Myeloma; Neomycin; Neoplasms; Phenylbutazone; Piperidones; Plants, Medicinal; Plants, Toxic; Polymyxin B; Propantheline; Secobarbital; Sulfathiazoles; Vitamins | 1989 |
Gene transfer test: so far, so good.
Topics: Federal Government; Humans; Immunization, Passive; Immunotherapy; Lymphocyte Transfusion; Neomycin; Neoplasms; Transfection | 1989 |
Approval expected for 'prelude' to gene therapy.
Topics: Drug Resistance; Genetic Therapy; Humans; Immunotherapy; Lymphocytes; Neomycin; Neoplasms | 1989 |
Patient isolator systems in cancer chemotherapy. The use of high-dose "nonabsorable" antibiotics in the reduction of bowel flora.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacitracin; Biological Assay; Blood Urea Nitrogen; Creatinine; Digestive System; Drug Therapy; Feces; Female; Humans; Intestinal Absorption; Kanamycin; Male; Middle Aged; Mouth Mucosa; Neomycin; Neoplasms; Nystatin; Patient Isolators; Polymyxins; Proteinuria; Sterilization; Sulfathiazoles | 1968 |
The administration of 5-fluorouracil by mouth.
Topics: Adenocarcinoma; Administration, Oral; Aged; Female; Fluorouracil; Gastrointestinal Neoplasms; Heart Failure; Humans; Hypothyroidism; Injections, Intravenous; Intestinal Neoplasms; Liver Neoplasms; Male; Middle Aged; Neomycin; Neoplasm Metastasis; Neoplasms; Tritium | 1974 |
[Effect of 5-fluorouracil on the transfer of the multiple drug resistance factor in bacteria].
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Chloramphenicol; Conjugation, Genetic; Culture Media; Depression, Chemical; Drug Resistance, Microbial; Erythromycin Ethylsuccinate; Escherichia coli; Fluorouracil; Folic Acid Antagonists; Humans; Kanamycin; Neomycin; Neoplasms; Staphylococcus; Stimulation, Chemical; Streptococcus; Streptomycin; Sulfonamides; Tetracycline; Time Factors; Transduction, Genetic | 1970 |
[Dissemination of bacteria with multiple drug resistance in patients in the Oncological Clinic].
Topics: Acridines; Anti-Bacterial Agents; Bacteria; Bacteriophage Typing; Chloramphenicol; Chlortetracycline; Coloring Agents; Erythromycin; Erythromycin Ethylsuccinate; Escherichia coli; Humans; Neomycin; Neoplasms; Oxacillin; Oxytetracycline; Penicillin Resistance; Pseudomonas aeruginosa; Staphylococcus; Streptococcus; Streptomycin; Sulfathiazoles | 1967 |